Understanding Natural Protection Against Cognitive Decline: The 100-plus Study
Principal Investigator
Henne Holstege, PhD
Alzheimer Center of the VU University Medical Center
Amsterdam, Netherlands
About the Research Project
Program
Award Type
Other
Award Amount
$100,000
Active Dates
August 01, 2026 - July 31, 2027
Grant ID
CA2027001
Goals
Maintaining the infrastructure of the 100-plus Study: cohort expansion and biomaterial collection
Unique and Innovative
These activities preserve the core infrastructure required to study why some individuals maintain cognitive health into extreme old age. This provides the foundation for the scientific phase of the 100-plus Study in which donated brains can ultimately be linked to the longitudinal cognitive, clinical, genetic and biomarker information collected from participants during life.
Foreseeable Benefits
1. Maintain nationwide recruitment and longitudinal follow-up.
Maintain the trained personnel and participant coordination required for nationwide recruitment and uninterrupted longitudinal follow-up throughout the funding period. Eligible and willing participants will continue to be offered home-based cognitive assessments and biosample collection.
2. Maintain and expand the brain-donation programme.
Maintain active recruitment of prospective brain donors and the coordination, technical support, sample processing and biobanking infrastructure required for the brain-donation programme. We aim to continue the current trajectory towards approximately 50 additional completed brain donations over the two-year Fidelity funding period. Each new donation will be processed, neuropathologically assessed, biobanked and linked to the participant’s longitudinal cognitive, clinical, genetic and biomarker data.
Related Grants
BrightFocus Foundation
Investigating the Role of Impaired Mitochondrial Dynamics in Exfoliation Glaucoma
Active Dates
July 24, 2023 - June 30, 2027
Principal Investigator
Arunkumar Venkatesan, PhD
Current Organization
SUNY Upstate Medical University
Investigating the Role of Impaired Mitochondrial Dynamics in Exfoliation Glaucoma
Active Dates
July 24, 2023 - June 30, 2027
Principal Investigator
Arunkumar Venkatesan, PhD
Current Organization
SUNY Upstate Medical University
BrightFocus Foundation
Foresight: Charity-Led Big Data for Ophthalmology
Active Dates
March 31, 2022 - March 30, 2024
Principal Investigator
Wen Hwa Lee, PhD
Current Organization
Action Against AMD
Foresight: Charity-Led Big Data for Ophthalmology
Active Dates
March 31, 2022 - March 30, 2024
Principal Investigator
Wen Hwa Lee, PhD
Current Organization
Action Against AMD
BrightFocus Foundation
Ocustatin™ for Treatment of Intermediate AMD
Active Dates
March 31, 2022 - February 28, 2024
Principal Investigator
John Edwards, MS, MBA
Current Organization
Drusolv Therapeutics
Ocustatin™ for Treatment of Intermediate AMD
Active Dates
March 31, 2022 - February 28, 2024
Principal Investigator
John Edwards, MS, MBA
Current Organization
Drusolv Therapeutics